Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cone-Rod Dystrophy”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03326336
What this trial is testing

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Who this might be right for
Non-syndromic Retinitis Pigmentosa
GenSight Biologics 10
Not applicableUnknownNCT03532633
What this trial is testing

Supply With Micronutrients (Purine and Pyrimidine) in Infants: a Prospective and Observational Study

Who this might be right for
Prematurity
University Hospital Tuebingen 150
Not applicableStudy completedNCT04459780
What this trial is testing

Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis

Who this might be right for
Psoriasis
Pierre Fabre Dermo Cosmetique 40
Testing effectiveness (Phase 2)Study completedNCT03116113
What this trial is testing

A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112

Who this might be right for
X-Linked Retinitis Pigmentosa
Biogen 50
Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Not applicableActive Not RecruitingNCT05429736
What this trial is testing

Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity

Who this might be right for
Incomplete Spinal Cord InjurySpasticity, Muscle
Shepherd Center, Atlanta GA 28
Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Not applicableStudy completedNCT02670980
What this trial is testing

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

Who this might be right for
Retinitis PigmentosaCone Rod DystrophyChoroideremia
Science Corporation 10
Not applicableLooking for participantsNCT07548944
What this trial is testing

Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance

Who this might be right for
Retinitis Pigmentosa (RP)Usher SyndromeCone Rod Dystrophy
Okuvision GmbH 30
Not applicableStudy completedNCT05305261
What this trial is testing

Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.

Who this might be right for
AntibodyVaccineMaternal+1 more
National University of Malaysia 197
Testing effectiveness (Phase 2)UnknownNCT01773278
What this trial is testing

Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Who this might be right for
Smith-Lemli-Opitz SyndromeCone-Rod DystrophyHearing Loss
University of Colorado, Denver 100
Testing effectiveness (Phase 2)Looking for participantsNCT06789445
What this trial is testing

Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Who this might be right for
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
BlueRock Therapeutics 54
Not applicableStudy completedNCT01497379
What this trial is testing

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Who this might be right for
Retinal DegenerationRetinitis Pigmentosa
Retina Implant AG 2
Early research (Phase 1)Looking for participantsNCT06395285
What this trial is testing

Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

Who this might be right for
ROSAH
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm) 12
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Testing effectiveness (Phase 2)Study completedNCT02110225
What this trial is testing

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

Who this might be right for
Retinitis Pigmentosa
Dompé Farmaceutici S.p.A 50
Testing effectiveness (Phase 2)Ended earlyNCT02338973
What this trial is testing

Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)

Who this might be right for
Inherited Ophthalmic DiseasesInherited Retinal Degeneration
National Eye Institute (NEI) 4
Not applicableUnknownNCT01506258
What this trial is testing

Autologous Stem Cells in Newborns With Oxygen Deprivation

Who this might be right for
Apgar; 0-3 at 1 MinuteMetabolic AcidosisHypoxia, Brain+1 more
Hospital Universitario Dr. Jose E. Gonzalez 20
Not applicableUnknownNCT05628272
What this trial is testing

MNCs for Bone Marrow Failure After Malignant Diseases Children Chemotherapy

Who this might be right for
Cord
Qianfoshan Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06467344
What this trial is testing

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

Who this might be right for
Stargardt DiseaseCone Rod DystrophyJuvenile Macular Degeneration+1 more
Ascidian Therapeutics, Inc 15
Next Page